Sasco Capital Inc. CT Decreases Stake in DENTSPLY SIRONA Inc. (NASDAQ:XRAY)

Sasco Capital Inc. CT trimmed its holdings in DENTSPLY SIRONA Inc. (NASDAQ:XRAY) by 14.2% during the 3rd quarter, Holdings Channel.com reports. The fund owned 854,940 shares of the medical instruments supplier’s stock after selling 141,500 shares during the period. DENTSPLY SIRONA accounts for about 3.5% of Sasco Capital Inc. CT’s portfolio, making the stock its 8th largest position. Sasco Capital Inc. CT’s holdings in DENTSPLY SIRONA were worth $23,135,000 as of its most recent SEC filing.

Other hedge funds have also recently made changes to their positions in the company. Intech Investment Management LLC purchased a new position in DENTSPLY SIRONA during the first quarter valued at $1,202,000. Covestor Ltd increased its holdings in shares of DENTSPLY SIRONA by 30.8% in the first quarter. Covestor Ltd now owns 3,073 shares of the medical instruments supplier’s stock worth $102,000 after purchasing an additional 723 shares during the last quarter. Seven Eight Capital LP purchased a new stake in shares of DENTSPLY SIRONA in the first quarter worth about $1,409,000. UniSuper Management Pty Ltd boosted its stake in DENTSPLY SIRONA by 1,153.6% during the first quarter. UniSuper Management Pty Ltd now owns 26,126 shares of the medical instruments supplier’s stock valued at $867,000 after buying an additional 24,042 shares during the last quarter. Finally, Boulder Hill Capital Management LP purchased a new position in DENTSPLY SIRONA during the 1st quarter valued at approximately $249,000. Institutional investors own 95.70% of the company’s stock.

Wall Street Analysts Forecast Growth

XRAY has been the topic of several recent research reports. Evercore ISI decreased their price objective on DENTSPLY SIRONA from $29.00 to $27.00 and set an “outperform” rating on the stock in a report on Tuesday, October 8th. Leerink Partnrs downgraded shares of DENTSPLY SIRONA from a “strong-buy” rating to a “hold” rating in a research note on Thursday, November 7th. Robert W. Baird dropped their price objective on shares of DENTSPLY SIRONA from $31.00 to $24.00 and set a “neutral” rating for the company in a research note on Friday, November 8th. StockNews.com upgraded shares of DENTSPLY SIRONA from a “hold” rating to a “buy” rating in a research report on Wednesday, November 6th. Finally, Leerink Partners downgraded shares of DENTSPLY SIRONA from an “outperform” rating to a “market perform” rating in a report on Thursday, November 7th. Six analysts have rated the stock with a hold rating and four have issued a buy rating to the stock. According to data from MarketBeat.com, the stock has a consensus rating of “Hold” and a consensus target price of $29.50.

DENTSPLY SIRONA Stock Up 1.0 %

Shares of NASDAQ XRAY opened at $18.46 on Tuesday. The company has a market cap of $3.67 billion, a P/E ratio of -8.92, a PEG ratio of 1.80 and a beta of 1.02. The firm has a 50-day simple moving average of $23.92 and a two-hundred day simple moving average of $25.38. DENTSPLY SIRONA Inc. has a 1 year low of $17.21 and a 1 year high of $37.60. The company has a debt-to-equity ratio of 0.72, a current ratio of 1.25 and a quick ratio of 0.84.

DENTSPLY SIRONA (NASDAQ:XRAY) last released its earnings results on Thursday, November 7th. The medical instruments supplier reported $0.50 earnings per share for the quarter, topping analysts’ consensus estimates of $0.48 by $0.02. The business had revenue of $951.00 million for the quarter, compared to analyst estimates of $939.10 million. DENTSPLY SIRONA had a positive return on equity of 12.62% and a negative net margin of 10.59%. The business’s revenue was up .4% compared to the same quarter last year. During the same quarter last year, the firm posted $0.49 earnings per share. Research analysts anticipate that DENTSPLY SIRONA Inc. will post 1.84 earnings per share for the current year.

About DENTSPLY SIRONA

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.